Andree Blaukat
Merck KGaA, Darmstadt (Germany) · 340 works · 4,762 citations · h-index 35
Top works
- PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect
- Adaptor Proteins Grb2 and Crk Couple Pyk2 with Activation of Specific Mitogen-activated Protein Kinase Cascades
- Pyk2 and FAK regulate neurite outgrowth induced by growth factors and integrins
- Characterization of c-kit expression in small cell lung cancer: prognostic and therapeutic implications.
- Ligand-induced Phosphorylation/Dephosphorylation of the Endogenous Bradykinin B2 Receptor from Human Fibroblasts
- Angiotensin-Converting Enzyme Inhibitor Ramiprilat Interferes With the Sequestration of the B 2 Kinin Receptor Within the Plasma Membrane of Native Endothelial Cells
- Matuzumab Binding to EGFR Prevents the Conformational Rearrangement Required for Dimerization
- Phosphorylation by casein kinase 2 induces PACS‐1 binding of nephrocystin and targeting to cilia
- Bradykinin-induced Internalization of the Human B2Receptor Requires Phosphorylation of Three Serine and Two Threonine Residues at Its Carboxyl Tail
- EMD 1214063 and EMD 1204831 Constitute a New Class of Potent and Highly Selective c-Met Inhibitors
- A selective chemical probe for exploring the role of CDK8 and CDK19 in human disease
- ACE inhibitor potentiation of bradykinin‐induced venoconstriction
- Determination of Bradykinin B2 Receptor in Vivo Phosphorylation Sites and Their Role in Receptor Function
- G Protein-Coupled Receptor-Mediated Mitogen-Activated Protein Kinase Activation through Cooperation of Gαq and Gαi Signals
- EGFR kinase domain mutations – functional impact and relevance for lung cancer therapy
- Mechanisms for 2‐methoxyestradiol‐induced apoptosis of prostate cancer cells
- Phosphorylation and regulation of a G protein–coupled receptor by protein kinase CK2
- Activation of mitogen‐activated protein kinase by the bradykinin B2 receptor is independent of receptor phosphorylation and phosphorylation‐triggered internalization
- Pharmacologic Inhibitor of DNA-PK, M3814, Potentiates Radiotherapy and Regresses Human Tumors in Mouse Models
- The selective c-Met inhibitor tepotinib can overcome epidermal growth factor receptor inhibitor resistance mediated by aberrant c-Met activation in NSCLC models.